Com​pany Information

Bacmuno is mission on creating a new era of bacterial-based immunotherapy against cancer. We hold the vison that no one should suffer from the burdens of cancer ,neither physiologically nor economically.  Our goal is using our unique biotechnology and advanced cancer treatment to develop cancer immunotherapy safely, efficiently and cost-friendly.

Bacmuno Biotechnology Limited is a Hong Kong based bio-pharmaceutical company devoting to the discovery, development and commercialization of novel cancer immunotherapies. 

By generically modifying a bacterium, Salmonella typhimurium, we developed cancer immunotherapies capable of effectively targeting the hypoxic regions of solid malignant tumors to block its growth, resistance, recurrence and metastases and cause its regression without damage to normal tissues. At the same time, the immunotherapies enlist the body’s own immune system to fight cancer and eventually to improve the treatment of solid malignant tumors.

Over a decade lab discover, our cancer immunotherapies’ technology granted the US, Europe and China patents. We fundamentally change the cancer treatment approaches and minimize side effects comparing to traditional chemotherapy and radiation.